Nephrosclerosis

Overview

Kidney’s response to systemic HTN — Benign vs Malignant, matches HTN’s benign vs accelerated/malignant phases. Early marker: macroalbuminuria (>150mg/day) or microalbuminuria (30-300mg/day).

Benign nephrosclerosis

Benign-phase HTN kidney. COMMONEST renal finding >60yr, worse with HTN/diabetes.

Morphology: Gross — both kidneys equal, ↓size/weight (~100g), adherent capsule, FINELY GRANULAR surface, V-SHAPED scars. Micro — hyaline arteriolosclerosis (homogeneous eosinophilic wall thickening) + intimal thickening (SM proliferation). Parenchyma (ischaemic): glomerular shrinkage, Bowman’s space collagen, periglomerular fibrosis, tubular atrophy, fine interstitial fibrosis.

Clinical: variable BP↑, headache/dizziness/palpitations. Eye changes but NO papilloedema. Normal renal function/urine early. Longstanding: mild proteinuria ±casts. Renal failure/uraemia rare.

Malignant nephrosclerosis

Malignant/accelerated HTN kidney. Uncommon — usually superimposed on ~5% pre-existing benign HTN, or secondary HTN; pure form in younger males.

Morphology: Gross — variable. Superimposed: small/shrunken, granular surface. PURE malignant HTN: enlarged, oedematous, petechial haemorrhages = “FLEA-BITTEN KIDNEY” (shared with post-strep GN, RPGN, HUS, TTP, HSP). Cut surface: red-yellow mottled.

Micro (usually superimposed on benign changes, MORE severe, arterioles):

• Necrotising arteriolitis — on hyaline arteriolosclerosis base; FIBRINOID NECROSIS, inflammatory cells, small haemorrhages
• Hyperplastic intimal sclerosis (“ONIONSKIN” proliferation) — concentric SM/collagen/BM laminae

Parenchyma: tubular loss, fine interstitial fibrosis, infarction necrosis foci.

Clinical: malignant HTN, BP ≥200/140. Headache, dizziness, impaired vision. PAPILLOEDEMA = distinguishes malignant from benign (key sign). Microscopic haematuria+proteinuria common. Function deteriorates during illness → azotaemia/uraemia if untreated. ~90% mortality within 1yr untreated (uraemia, CHF, CVA).

Related: thrombotic microangiopathy

Platelet-fibrin thrombi in renal arterioles/glomeruli → ARF. Causes: infections (E.coli, Shigella, Pseudomonas), drugs (mitomycin, cisplatin, cyclosporine), autoimmune (scleroderma, SLE), TTP, HUS, pregnancy/pre-eclampsia, malignant HTN.

Pathogenesis: ENDOTHELIAL INJURY = common trigger → plasma leaks subendothelially + promotes thrombosis. Clinical: MAHA, thrombocytopenia, DIC, renal failure.

Morphology: closely resembles malignant nephrosclerosis — fibrinoid arteriolar necrosis, microthrombi, intimal oedema, glomerular consolidation/necrosis/congestion. Massive involvement = generally lethal.

Clinical relevance

Papilloedema = single sign reliably separating benign from malignant nephropathy — signals accelerated phase’s much higher mortality + urgent BP control need — high-stakes finding, not incidental. V-shaped scars (benign nephrosclerosis) + granular scars (chronic GN) + U-shaped scars (chronic pyelonephritis) = compact 3-way mnemonic for small contracted kidney causes — scar shape narrows differential immediately. “Flea-bitten kidney” shared across malignant nephrosclerosis/post-strep GN/RPGN/HUS/TTP/HSP = single gross appearance results from ANY widespread small-vessel injury+petechial haemorrhage process — narrows category (acute small-vessel injury), not single diagnosis. Thrombotic microangiopathy’s morphologic resemblance to malignant nephrosclerosis = shared final pathway (endothelial injury→fibrinoid necrosis+microthrombosis) despite entirely different triggers — vascular injury patterns in kidney often convergent, not cause-specific.

Overview

Nephrosclerosis describes the kidney’s response to systemic hypertension, in two forms — benign and malignant — corresponding to hypertension’s benign and accelerated/malignant phases. An early clinical marker of hypertensive renal injury (and cardiovascular risk) is macroalbuminuria (>150 mg/day, or urine albumin:creatinine >300 mg/g) or microalbuminuria (30–300 mg/day, or ratio 30–300 mg/g).

Benign Nephrosclerosis

The kidney of benign-phase hypertension — the most common renal finding in people over 60, with severity increased by coexisting hypertension or diabetes.

Morphology: gross — both kidneys equally affected, reduced size/weight (~100 g or less), capsule adherent, finely granular surface with V-shaped scarring. Micro — two vascular changes: hyaline arteriolosclerosis (homogeneous eosinophilic wall thickening of small vessels) and intimal thickening (smooth muscle proliferation). Parenchymal consequence (from resulting ischaemia): glomerular shrinkage, collagen deposition in Bowman’s space, periglomerular fibrosis, tubular atrophy, fine interstitial fibrosis.

Clinical features: variable BP elevation with headache, dizziness, palpitations, nervousness; eye-ground changes but no papilloedema; renal function/urine normal early; longstanding disease may show mild proteinuria with hyaline/granular casts; renal failure/uraemia are rare.

Malignant Nephrosclerosis

The renal lesion of malignant/accelerated hypertension. Uncommon — usually a superimposed complication in ~5% of pre-existing benign essential hypertension, or in secondary hypertension (e.g. chronic renal disease); a pure form also occurs, more often in younger males.

Morphology: gross — variable; when superimposed on pre-existing benign nephrosclerosis, kidneys are small/shrunken with a finely granular surface; in pure malignant hypertension, kidneys are enlarged, oedematous, with petechial haemorrhages — “flea-bitten kidney” (a finding shared with acute post-streptococcal GN, RPGN, HUS, TTP, HSP — worth recognising as a shared appearance across several distinct diseases). Cut surface: red-and-yellow mottled.

Micro — changes are typically superimposed on benign nephrosclerosis, and are more severe, involving arterioles specifically:

• Necrotising arteriolitis — develops on a base of hyaline arteriolosclerosis; fibrinoid necrosis of the vessel wall, scattered acute inflammatory cells, small haemorrhages.
• Hyperplastic intimal sclerosis (“onionskin” proliferation) — concentric laminae of proliferated smooth muscle, collagen, basement membrane.

Ischaemic parenchymal consequence: tubular loss, fine interstitial fibrosis, foci of infarction necrosis.

Clinical features: malignant/accelerated hypertension, BP ≥200/140 mmHg. Headache, dizziness, impaired vision. Papilloedema is the feature that distinguishes malignant from benign phase. Microscopic haematuria and proteinuria common; renal function deteriorates during the illness; untreated malignant hypertension rapidly produces azotaemia/uraemia. ~90% mortality within one year without aggressive treatment, from uraemia, CHF, or cerebrovascular accident.

Related: Thrombotic Microangiopathy

A group of diseases sharing platelet-fibrin thrombus formation in renal arterioles/glomeruli, culminating in acute renal failure. Causes: infections (E. coli, Shigella, Pseudomonas), drugs (mitomycin, cisplatin, cyclosporine), autoimmune disease (scleroderma, SLE), TTP, HUS, pregnancy/pre-eclampsia, malignant hypertension.

Pathogenesis: endothelial injury is the common trigger, causing plasma constituents to pass into the subendothelial zone and promoting thrombosis. Clinical picture: microangiopathic haemolytic anaemia, thrombocytopenia, DIC, renal failure.

Morphology: closely resembles malignant nephrosclerosis — fibrinoid arteriolar necrosis, microvascular thrombi, arteriolar intimal oedema, glomerular consolidation/necrosis/congestion. Massive renal involvement is generally lethal.

Clinical Relevance

• Papilloedema is the single clinical sign that reliably separates benign from malignant hypertensive nephropathy — its presence signals the accelerated phase’s markedly higher mortality and the need for urgent blood pressure control, making it a genuinely high-stakes physical finding rather than an incidental eye-exam detail.
• The V-shaped scars of benign nephrosclerosis, alongside the granular scars of chronic GN and the U-shaped scars of chronic pyelonephritis, form a compact three-way mnemonic set for the causes of a small contracted kidney — recognising the scar shape on gross pathology or imaging narrows the differential immediately, before any other test.
• “Flea-bitten kidney” being shared across malignant nephrosclerosis, post-streptococcal GN, RPGN, HUS, TTP, and HSP is a useful reminder that a single striking gross appearance can result from any process causing widespread small-vessel injury with petechial haemorrhage — the appearance narrows the category (acute small-vessel injury) without narrowing to a single diagnosis.
• Thrombotic microangiopathy’s morphologic resemblance to malignant nephrosclerosis reflects a shared final pathway — endothelial injury triggering fibrinoid necrosis and microthrombosis — even though the triggers (infection, drugs, autoimmune disease, malignant hypertension itself) are entirely different, reinforcing that vascular injury patterns in the kidney are often convergent rather than cause-specific.

• Benign vs malignant nephrosclerosis: vascular lesion, parenchymal consequence, and clinical marker compared
• Three causes of small contracted kidney distinguished by scar shape (granular/U-shaped/V-shaped)